Intellective Bio Overview
- Year Founded
-
2018
- Status
-
IPO Registration
- Employees
-
906
- Latest Deal Type
-
IPO
- (Announced)
- Investors
-
13
Intellective Bio General Information
Description
Provider of contract development and manufacturing organization (CDMO) services designed to support the development and large-scale commercial production of macromolecular biopharmaceuticals. The company offers process development, quality control, clinical and commercial GMP production, and regulatory filing services for monoclonal antibodies, antibody-drug conjugates (ADCs), and recombinant proteins, enabling biotechnology and pharmaceutical enterprises to accelerate drug time-to-market and achieve cost-effective mass production through its extensive bioreactor capacity and specialized production lines.
Contact Information
Website
www.intellectivebio.comCorporate Office
- Number 96, Yinhe Road, Southeast Street
- Changshu
- Suzhou, Jiangsu 215500
- China
Corporate Office
- Number 96, Yinhe Road, Southeast Street
- Changshu
- Suzhou, Jiangsu 215500
- China
Intellective Bio Timeline
Intellective Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. IPO | 01-Jun-2026 | Announced | Generating Revenue | |||
| 9. Secondary Transaction - Private | 18-Mar-2026 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series C1) | 04-Jul-2024 | Completed | Generating Revenue | |||
| 7. Secondary Transaction - Private | 01-Mar-2024 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C) | 18-Aug-2022 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | 31-May-2022 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B1) | 12-Jul-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 28-Jun-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A1) | 07-May-2021 | $7.68M | $24.4M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 11-Nov-2020 | $16.7M | $16.7M | Completed | Generating Revenue |
Intellective Bio Signals
Intellective Bio Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Anhui Capital | Asset Manager | Minority | ||
| Chongqing Kexing Kechuang Equity Investment Fund Management | Growth/Expansion | Minority | ||
| Eastern Bell Venture Capital | Venture Capital | Minority | ||
| Quzhou State-owned Assets Security Capital Management | Growth/Expansion | Minority | ||
| Shenzhen Yunqi Private Equity Investment Fund Management | Growth/Expansion | Minority |
Intellective Bio Investments (2)
Intellective Bio’s most recent deal was a Later Stage VC with Aismay. The deal was made on 29-Jul-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Aismay | 29-Jul-2026 | Later Stage VC | Drug Discovery | ||
| Leads Biolabs | 27-Nov-2024 | Secondary Transaction - Private | Drug Discovery |
Intellective Bio FAQs
-
When was Intellective Bio founded?
Intellective Bio was founded in 2018.
-
Where is Intellective Bio headquartered?
Intellective Bio is headquartered in Suzhou, China.
-
What is the size of Intellective Bio?
Intellective Bio has 906 total employees.
-
What industry is Intellective Bio in?
Intellective Bio’s primary industry is Biotechnology.
-
Is Intellective Bio a private or public company?
Intellective Bio is a Private company.
-
What is Intellective Bio’s current revenue?
The current revenue for Intellective Bio is .
-
How much funding has Intellective Bio raised over time?
Intellective Bio has raised $187M.
-
Who are Intellective Bio’s investors?
Anhui Capital, Chongqing Kexing Kechuang Equity Investment Fund Management, Eastern Bell Venture Capital, Quzhou State-owned Assets Security Capital Management, and Shenzhen Yunqi Private Equity Investment Fund Management are 5 of 13 investors who have invested in Intellective Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process